key: cord-0788913-5n6b04mx
authors: Nuovo, Gerard J.; Magro, Cynthia; Mikhail, Adel
title: Cytologic and molecular correlates of SARS-CoV-2 infection of the nasopharynx
date: 2020-07-07
journal: Ann Diagn Pathol
DOI: 10.1016/j.anndiagpath.2020.151565
sha: 321af25fcf2c4bae80b5d2c2cde423585fec4a61
doc_id: 788913
cord_uid: 5n6b04mx

Infection by SARS-CoV-2 commonly begins in the nasopharynx, and the cytologic and molecular correlates are not characterized. Fifty-eight cytologic preps (20 oral and 38 from the nasopharynx) were obtained from ten patients and analyzed in a blinded fashion for SARS-CoV-2 spike and envelope protein by immunohistochemistry and viral RNA by in situ hybridization. qRTPCR identified three positive cases and seven controls; the three cases reported mild symptoms that resolved in 2–3 days. Blinded analyses confirmed the presence of the SARS-CoV-2 spike and envelope proteins and viral RNA in the three cases and viral absence in the seven controls. A signal for the positive cases was evident in each nasopharyngeal and none of the oral samples. Viral RNA/proteins localized exclusively to glandular cells and was present in high copy number. Blinded analysis of the cytology documented that the glandular cells infected by SARS-CoV-2 showed marked degeneration with ciliocytophthoria; viral inclusions were not evident. Co-expression analysis showed viral infected cells had increased apoptosis, marked by strong expression of activated caspase 3. Weekly serial testing of two of the cases showed persistence of productive viral infection for up to 2 weeks after symptom onset. It is concluded that the target cell of SARS-CoV-2 in the head and neck region is the glandular cell of the nasal passages, that viral infection is lytic and associated with high copy number that facilitates viral spread. The method outlines a simple, rapid test for productive SARS-CoV-2 based on immunohistochemistry or in situ hybridization of the glandular cells from the nasopharynx.

SARS-CoV-2, a coronavirus first identified at the end of 2019, is responsible for the most serious pandemic of the last 100 years that, as of this writing, has caused more than 2 million documented cases and, most likely, over 20 million infections when subclinical disease is included. It is well documented that the infection most commonly originates in the head and neck region with both nasopharyngeal and oral swabs being used for diagnosis of viral RNA either by qRTPCR or next generation sequencing (NGS).

Although there is some disparity in the literature, it is generally agreed that nasopharyngeal swabs are superior to oral swabs for diagnostic purposes (1-3). It has also been documented that people with mild symptoms can be positive for viral RNA that can persist for weeks (3) . One pitfall of the tests for the SARS-CoV-2 RNA is that they cannot determine if the virus is infectious; this would require demonstration of viral RNA and the protein coat which includes the spike protein, which attaches to the cell receptor, and the envelope protein, which serves as support for the spike protein (4).

The histopathology of severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS), both also due to coronaviruses, includes infection of the upper and lower respiratory tracts. However, in SARS and MERS, the primary cell target of the virus in the lung is the alveolar pneumocyte (type I and type II) which induces a strong cytokine response that includes IL6, TNF alpha, IL-1B and CCL2 (4). The end result for 10% and 35% of infected people, respectively, is death associated with acute respiratory distress syndrome with its characteristic hyaline membrane disease (4) . Early data on the histopathology of COVID-19 suggests that the respiratory tract is indeed the primary entry/site of serious disease but that the target cell in the lung is the alveolar A major issue regarding the diagnosis of SARS-CoV-2 is the acute shortage of many essential ingredients for performing the standard tests from nasopharyngeal swabs (qRTPCR and NGS) (1) . These currently used tests for viral RNA cannot show the cell type(s) that are viral targets or if the infection is productive. We explored whether formalin fixed cytology smears prepared from the oral cavity or nasopharynx could be used to detect active coronavirus infection using standard immunohistochemistry and in situ based methods, much like human papillomavirus can be detected in Pap smears.

J o u r n a l P r e -p r o o f

Standard nasopharyngeal and oral swabs were prepared from ten people being tested for SARS-CoV-2RNA using a standard qRTPCR test. Three of the people had reported mild symptoms (low-grade fever up to 100F, mild cough, mild fatigue) that lasted from 1-3 days. The other people had possible exposure to SARS-CoV-2 infected people, though in no case was contact with a verified infected person documented. Four swabs of each region were done per site, then spread on four unstained PLUS slides, and air-dried for 30 minutes. Then the slides were placed in 10% buffered formalin overnight, washed in distilled water, and air-dried. One swab/site was stained with hematoxylin and eosin for cytologic analysis. The other three slides were used for molecular/viral testing. One additional swab was taken/site, and placed in the viral collection media for standard qRTPCR testing. SARS-CoV-2 RNA was detected in the nasopharyngeal swabs from the cases near the onset of symptoms (panel A, arrow); note the marked degenerative changes in some of

SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients

Presumed Asymptomatic Carrier Transmission of COVID-19

Molecular pathology of emerging coronavirus infections

Complement activation is associated with the thrombotic microvascular injury of severe COVID-19 disease

In situ molecular pathology and co-expression analyses

Nuovo G False-positive results in diagnostic immunohistochemistry are related to horseradish peroxidase conjugates in commercially available assays

Morris D Oncolytic immunotherapy and bortezomib synergy improves survival of refractory multiple myeloma in a preclinical model

Colonization of severe acute respiratory syndrome-associated coronavirus among health-care workers screened by nasopharyngeal swab

Isolation of Complete Equine Encephalitis Virus Genome from Human Swab Specimen

Paediatric nasopharyngeal cytology: a new diagnostic opportunity?

BioFire FilmArray Respiratory Panel 2 for Detection of Viruses and Bacteria in Nasopharyngeal Swab Samples

Lindh M Pathogen Clearance and New Respiratory Tract Infections Among Febrile Children in Zanzibar Investigated With Multitargeting Real-Time Polymerase Chain Reaction on Paired Nasopharyngeal Swab Samples

Aaby P Comparison of nasopharyngeal aspirate and nasal swab specimens for detection of respiratory syncytial virus in different settings in a developing country

Endothelial cell infection and endotheliitis in COVID-19. The Lancet

The authors are most appreciative of the photodocumentation provided by Dr. Margaret Nuovo.

The authors have no conflicts of interest to report.

J o u r n a l P r e -p r o o f